Prokidney (PROK) Common Equity (2021 - 2026)

Prokidney (PROK) has 6 years of Common Equity data on file, last reported at -$1.0 billion in Q1 2026.

• On a quarterly basis, Common Equity fell 2.53% year-over-year to -$1.0 billion in Q1 2026; TTM through Mar 2026 was -$1.0 billion, a 2.53% decrease from a year earlier, with the FY2025 full-year figure at -$1.0 billion, down 1.63% from the prior year.
• Common Equity for Q1 2026 stood at -$1.0 billion, down from -$1.0 billion in the prior quarter.
• Over the last five years, Common Equity for PROK reached as high as $20.2 million in Q1 2022 and fell as low as -$1.6 billion in Q1 2023.
• Historically, Common Equity has averaged -$963.1 million across 5 years, with a median of -$1.0 billion in 2025.
• Across the five-year window, Common Equity tumbled 20327.23% in 2023 and jumped 31.56% in 2024, its largest moves.
• Year by year, Common Equity stood at -$1.1 billion in 2022, then declined by 0.62% to -$1.1 billion in 2023, then rose by 9.83% to -$995.0 million in 2024, then dropped by 1.63% to -$1.0 billion in 2025, then dropped by 1.24% to -$1.0 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$1.0 billion in Q1 2026, -$1.0 billion in Q4 2025, and -$1.0 billion in Q3 2025.